Chawla Lakhmir S 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Sep 2, 2020
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-08-31$3.57/sh+550$1,964→ 13,161 total - Award
Employee Stock Option (Right to Buy)
2020-08-31+550→ 550 totalExercise: $4.20Exp: 2030-08-31→ Common Stock (550 underlying)
Footnotes (2)
- [F1]These shares were acquired on 08/31/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.